Philippe Moreau^1*, Tamás Masszi, MD², Norbert Grzasko, MD, PhD^3*, Nizar J Bahlis, MD⁴, Markus Hansson^5*, Ludek Pour, MD^6*, Irwindeep Sandhu, MD⁷, Peter Ganly, BMBCh, PhD^8*, Bartrum W Baker, MBChB, FRACP, FRCPA⁹, Sharon Jackson, MBChB, FRACP, FRCPA¹⁰, Anne-Marie Stoppa, MD¹¹, David R Simpson, MBChB, FRACP, FRCPA¹², Peter Gimsing, MD, DMSci^13*, Antonio Palumbo¹⁴, Laurent Garderet, MD¹⁵, Michele Cavo^16*, Shaji K. Kumar, MD¹⁷, Cyrille Touzeau, MD^18*, Francis Buadi, MD¹⁷, Jacob P. Laubach, MD¹⁹, Jianchang Lin, PhD^20*, Deborah Berg, RN, MSN²⁰, Alessandra DiBacco, PhD^20*, Ai-Min Hui, MD, PhD²⁰ and Paul G. Richardson, MD²¹

¹University of Nantes, Nantes, France
²Dept. of Haematology and Stem Cell Transplantation, St. István and St. László Hospital of Budapest, Budapest, Hungary
³Department of Haemato-oncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland
⁴University of Calgary, Southern Alberta Cancer Research Institute, Calgary, AB, Canada
⁵Department of Hematology, Skĺne University Hospital, Lund University, Lund, Sweden
⁶University Hospital Brno, Brno, Czech Republic
⁷Department of Medicine, Division of Hematology, University of Alberta, Edmonton, AB, Canada
⁸Department of Haematology, Christchurch Hospital, Christchurch, New Zealand
⁹Department of Haematology, Palmerston North Hospital, Palmerston North, New Zealand
¹⁰Department of Haematology, Middlemore Hospital, Auckland, New Zealand
¹¹Department of Hematology, Institut Paoli-Calmettes, Marseille, France
¹²Department of Haematology, North Shore Hospital, Auckland, New Zealand
¹³Department of Hematology, University Hospital Rigshospitalet, Copenhagen, Denmark
¹⁴University of Torino, Torino, Italy
¹⁵Hôpital Saint Antoine, Paris, France
¹⁶Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy
¹⁷Division of Hematology, Mayo Clinic, Rochester, MN
¹⁸Nantes University Hospital, Hôtel Dieu, Nantes, France
¹⁹Dana-Farber Cancer Institute, Boston, MA
²⁰Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
²¹Division of Hematologic Malignancy, Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Jeffrey A Zonder, MD¹, Saad Usmani^2*, Emma C. Scott, MD³, Craig C. Hofmeister, MD⁴, Nikoletta Lendvai, MD PhD⁵, Jesus G. Berdeja, MD⁶, Larry D. Anderson Jr., MD, PhD⁷, Parameswaran Hari, MBBS, MD, MRCP⁸, Seema Singhal, M.D.⁹, Gregory Orloff, MD¹⁰, Michael Craig, MD¹¹, Jason Valent, MD¹², Wes Lee^13*, Lowell Hart^14*, J Hrom^15*, Stephano Tarantolo^16*, Edward Faber, DO^17*, Gary J Schiller, MD¹⁸, Jennifer Schreiber, BS^19*, Colleen Oliver, MSc^19*, Selena A Rush, BS^20*, Brian Tunquist²¹, Mieke Ptaszynski^19* and Noopur S. Raje, MD²²

¹Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI
²Levine Cancer Institute/Carolinas Healthcare System, Charlotte, NC
³Center for Hematologic Malignancies, The Knight Cancer Institute, Oregon Health and Science University and the Knight Cancer Institute, Portland, OR
⁴The Ohio State University, Columbus, OH
⁵Memorial Sloan-Kettering Cancer Center, New York, NY
⁶Sarah Cannon Research Institute, Nashville, TN
⁷Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
⁸Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
⁹Robert H. Lurie Comprehensive Cancer Center, Division of Hem./Onc., Northwestern University Feinberg School of Medicine, Chicago, IL
¹⁰Fairfax Northern Virginia Hematology Oncology, Fairfax, VA
¹¹West Virginia University Hospitals, Inc., Morgantown, WV
¹²Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH
¹³St. Joseph Healthcare, Santa Rosa, CA
¹⁴Florida Cancer Specialists, Fort Myers, FL
¹⁵Forest General Cancer Center, Hattiesburg, MS
¹⁶Nebraska Cancer Specialists, Omaha, NE
¹⁷Oncology Hematology Care - Blue Ash, Cincinnati, OH
¹⁸University of California Los Angeles Medical Center, Los Angeles, CA
¹⁹Array BioPharma, Boulder, CO
²⁰Array BioPharma Inc., Boulder, CO
²¹Array Biopharma, Boulder, CO
²²Massachusetts General Hospital Cancer Center, Boston, MA

Philippe Moreau^1*, Douglas Joshua², Wee-Joo Chng³, Antonio Palumbo⁴, Hartmut Goldschmidt⁵, Roman Hájek⁶, Thierry Facon⁷, Heinz Ludwig⁸, Ludek Pour, MD^9*, Ruben Niesvizky¹⁰, Albert Oriol, MD^11*, Laura Rosińol^12*, Aleksandr Suvorov^13*, Gianluca Gaidano¹⁴, Tomas Pika^15*, Katja Weisel^16*, Vesselina Goranova-Marinova^17*, Heidi H. Gillenwater¹⁸, Nehal Mohamed^18*, Shibao Feng^18* and Meletios Dimopoulos¹⁹

¹University of Nantes, Nantes, France
²Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
³National University Cancer Institute, National University Health System, Singapore, Singapore
⁴University of Torino, Torino, Italy
⁵Heidelberg Medical University, Heidelberg, Germany
⁶University Hospital Ostrava, Ostrava, Czech Republic
⁷CHRU Lille Hôpital Claude Huriez, Lille, Lille, France
⁸Department of Medicine I, Wilhelminenhospital, Wilhelminen Cancer Research Institute, Vienna, Austria
⁹University Hospital Brno, Brno, Czech Republic
¹⁰Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY
¹¹Institut Catalŕ d’Oncologia, Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain
¹²Hospital Clínic de Barcelona, Barcelona, Spain
¹³First Republican Clinical Hospital of Udmurtia, Izhevsk, Russia
¹⁴Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
¹⁵University Hospital Olomouc, Olomouc, Czech Republic
¹⁶Universitatsklinikum Tubingen, Tubingen, Germany
¹⁷University Multiprofile Hospital for Active Treatment, Plovdiv, Bulgaria
¹⁸Onyx Pharmaceuticals, Inc., an Amgen subsidiary, South San Francisco, CA
¹⁹National and Kapodistrian University of Athens, Athens, Greece

Herve Avet-Loiseau^1*, Cyrille Hulin^2*, Lofti Benboubker^3*, Meletios A. Dimopoulos⁴, Andrew Belch⁵, Donna Reece⁶, John Catalano⁷, Antonio Pinto^8*, Heinz Ludwig⁹, Nizar J Bahlis¹⁰, Michele Cavo^11*, Michel Attal¹², Philippe Moreau^13*, Lugui Qiu^14*, Richard LeBlanc¹⁵, Rik Schots^16*, S. Vincent Rajkumar¹⁷, Jennifer Marek^18*, Guang Chen^18*, Wai Yiu^18*, Annette Ervin-Haynes¹⁸ and Thierry Facon¹⁹

¹Unite de Genomique du Myelome, CHU Rangueil, Toulouse, France
²CHU BORDEAUX, Bordeaux, France
³CHU Tours Hopital Bretonneau, Tours, France
⁴National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
⁵Cross Cancer Institute, Edmonton, AB, Canada
⁶Princess Margaret Cancer Centre, Toronto, ON, Canada
⁷Frankston Hospital, Frankston, Victoria, Australia
⁸Hematology-Oncology and Stem Cell Transplantation Unit, Istituto Nazionale Tumori, Naples, Italy
⁹Department of Medicine I, Wilhelminenhospital, Wilhelminen Cancer Research Institute, Vienna, Austria
¹⁰Hematology and Bone Marrow Transplantation, University of Calgary, Tom Baker Cancer Centre, Calgary, AB, Canada
¹¹Serŕgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
¹²CHU Toulouse Hopital Purpan, Toulouse, France
¹³Nantes University Hospital, Hôtel‐Dieu, Nantes, France
¹⁴Blood Disease Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin, China
¹⁵Division of Hematology and Medical Oncology, Department of Medicine, Maisonneuve-Rosemont Hospital, University of Montreal, Montreal, QC, Canada
¹⁶Myeloma Center, University Hospital VUB, Brussels, Belgium
¹⁷Division of Hematology, Mayo Clinic, Rochester, MN
¹⁸Celgene Corporation, Summit, NJ
¹⁹Maladies du Sang, Hôpital Claude Huriez, CHRU Lille, Lille, France

Hervé Avet-Loiseau, MD^1*, Rafael Fonseca, MD², David S Siegel, MD, PhD³, Meletios A. Dimopoulos⁴, Ivan Spicka^5*, Tamás Masszi⁶, Roman Hájek⁷, Laura Rosińol^8*, Vesselina Goranova-Marinova^9*, Georgi Mihaylov^10*, Vladimír Maisnar^11*, Maria-Victoria Mateos¹², Michael Wang, MD¹³, Ruben Niesvizky, MD¹⁴, Albert Oriol^15*, Andrzej Jakubowiak, MD, PhD¹⁶, Jiri Minarik¹⁷, Antonio Palumbo¹⁸, William Bensinger, MD^19*, Vishal Kukreti²⁰, Dina Ben-Yehuda^21*, Margaret Tonda^22*, Mihaela Obreja^22* and Philippe Moreau^23*

¹Centre de Recherche en Cancérologie de Toulouse Institut National de la Santé, Toulouse, France
²Mayo Clinic, Scottsdale, AZ
³Hackensack University Medical Center, John Theurer Cancer Center, Hackensack, NJ
⁴National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
⁵Department of Internal Medicine, University Hospital, Praha, Czech Republic
⁶St István and St Laszlo Hospital, Budapest, Hungary
⁷University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
⁸Hospital Clínic de Barcelona, Barcelona, Spain
⁹Clinic University Multiprofile Hospital for Active Treatment, Plovdiv, Bulgaria
¹⁰Queen Joanna University Hospital, Sofia, Bulgaria
¹¹Charles University Faculty Hospital and Faculty of Medicine, Hradec Králové, Czech Republic
¹²Hematology Department, University Hospital of Salamanca/IBSAL, Salamanca, Spain
¹³Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁴Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY
¹⁵Institut Catalŕ d’Oncologia, Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain
¹⁶University of Chicago Medical Center, Chicago, IL
¹⁷University Hospital Olomouc, Olomouc, Czech Republic
¹⁸University of Torino, Torino, Italy
¹⁹Fred Hutchinson Cancer Research Center, Seattle, WA
²⁰Princess Margaret Cancer Centre, Toronto, ON, Canada
²¹Hadassah-Hebrew University Medical Centre, Jerusalem, Israel
²²Onyx Pharmaceuticals, Inc., an Amgen subsidiary, South San Francisco, CA
²³University of Nantes, Nantes, France

Ashutosh Wechalekar, MD, FRCPath, Carol Whelan, MD FRCP^*, Helen Lachmann, MD FRCP^*, Marianna Fontana, MD^*, Shameem Mahmood, FRCPath^*, Julian D Gillmore, MD PhD FRCP^* and Philip N Hawkins, MD PhD FMedSci^*

National Amyloidosis Centre, University College London, London, United Kingdom